Skip to content

Leiden Longevity Study follow-up study

Leiden Longevity Study follow-up study - LLS follow-up study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52307
Enrollment
500
Registered
2021-08-30
Start date
2021-11-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

veroudering, cardio-metabole gezondheid, darmgezondheid, cognitie en leeftijdsgerelateerde ziektes ageing healthy ageing

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Participated in the first wave of the Leiden Longevity Study in 2002, with at least a baseline blood sample present and preferably participated in the third round of the LLS in 2009-2010, or in at least one other follow-up study of the LLS - Able to give written informed consent - Willing and able to visit the research centre in Leiden with public or private transport - Willing and able to follow the study protocol

Exclusion criteria

Exclusion criteria: - Not able to give written informed consent - Not able to visit the research center in Leiden with public or private transport - Not able to follow the study protocol

Design outcomes

Primary

MeasureTime frame
We will investigate changes in cardio-metabolic, cognitive, and physical performance over time and obtain novel biomarker in this follow up study. Phenotypic characteristics to be collected: Cardio-metabolic measurements o (1H NMR based) Nightingale metabolomics o Blood pressure o Body composition (Bioelectrical impedance analysis (BIA)) o Heart rate and heart rate variability (Electrocardiogram (ECG) (novel at follow-up)) Cognitive function o Attention (Stroop colour word test) o Processing speed (Digit Symbol Substitution Test (DSST)) o Memory (15-Picture learning test (PWL)) o Global cognitive function (Mini-Mental State Examination (MMSE) (novel at follow-up)) o Language (Animal fluency (novel at follow-up)) o Subjective memory complaints (novel at follow-up) Physical performance o Hand grip strength o Short Physical Performance Battery (SPPB) o Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) questionnaires (novel at follow-up) Gut health (novel at follow-up): o Stool sample to perform gut microbiome 16S measurements o Questionnaire on stool sample and Bristol Stool Chart o Gastrointestinal symptom rating scale (GSRS) questionnaire Habitual dietary intake o Food Frequency Questionnaire (FFQ) Physical activity o Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH) (novel at follow-up) Anthropometric measurements o Heigth o Weight o Hip and waist circumference Mood, depression, apathy, and quality of life o Several general questions on well-being o Center for Epidemiological Studies Depression Scale (CES-D) o EuroQol five dimensions questionnaire (EQ-5D-3L) (novel at follow-up) o EQ-VAS (novel at follow-up) Medication use o List from pharmacy o Check of the pharmacy list with participant Medical history o List from GP o Check of the GP list with participant General questionnaire on marital status, occupation, education, alcohol use, smoking, self-rated health, a

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)